Genetic alterations in childhood relapsed high hyperdiploid B-cell acute lymphoblastic leukemia

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
Hannover, Medizinische Hochschule Hannover, Dissertation, 2024

Ereignis
Veröffentlichung
(wo)
Hannover
(wer)
Bibliothek der Medizinischen Hochschule Hannover
(wann)
2024
Urheber
Leonie Anne, Braun
Beteiligte Personen und Organisationen
Steinemann, Doris
Institut für Humangenetik

DOI
10.26068/mhhrpm/20240910-005
URN
urn:nbn:de:101:1-2409190837570.019958592050
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:34 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Leonie Anne, Braun
  • Steinemann, Doris
  • Institut für Humangenetik
  • Bibliothek der Medizinischen Hochschule Hannover

Entstanden

  • 2024

Ähnliche Objekte (12)

Relapsed Acute Lymphoblastic Leukemia

Relapsed Acute Lymphoblastic Leukemia

DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia

DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia

Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia

Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia

TARGET based m6A methylation-related genes predict prognosis relapsed B-cell acute lymphoblastic leukemia

TARGET based m6A methylation-related genes predict prognosis relapsed B-cell acute lymphoblastic leukemia

Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study

Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study

Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia

Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia

Mutational mechanisms in multiply relapsed pediatric acute lymphoblastic leukemia

Mutational mechanisms in multiply relapsed pediatric acute lymphoblastic leukemia

Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures

Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures

Benefit–Risk Assessment of Blinatumomab in the Treatment of Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

Benefit–Risk Assessment of Blinatumomab in the Treatment of Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

Clonal evolution of the 3D chromatin landscape in patients with relapsed pediatric B-cell acute lymphoblastic leukemia

Clonal evolution of the 3D chromatin landscape in patients with relapsed pediatric B-cell acute lymphoblastic leukemia

PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia

PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia

Inotuzumab Ozogamicin Monotherapy as an Outpatient Salvage Treatment in Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia: Compassionate Access

Inotuzumab Ozogamicin Monotherapy as an Outpatient Salvage Treatment in Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia: Compassionate Access

Verbundene Objekte